Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-107811
Filing Date
2024-10-10
Accepted
2024-10-10 21:01:44
Documents
2
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425730-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2425730-3_3seq1.xml 3 3542
2 EXHIBIT 24 tm2425730d3_ex24.htm EX-24 7220
  Complete submission text file 0001104659-24-107811.txt   12263
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address
Thadhani Ravi I. (Reporting) CIK: 0002032665 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42365 | Film No.: 241366167